Genomics in Cancer Care Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized medicine, Drug discovery & development, Research), By Technology (Genome sequencing, PCR, Microarrays, Nucleic acid extraction & purification, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Genomics in Cancer Care market size is poised to register 15.45% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Genomics in Cancer Care market across By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized medicine, Drug discovery & development, Research), By Technology (Genome sequencing, PCR, Microarrays, Nucleic acid extraction & purification, Others).
The genomics in cancer care market is witnessing rapid growth, fueled by advancements in genomic technologies, increasing understanding of cancer biology, and expanding applications in precision oncology and targeted therapy. Genomic profiling of tumors enables oncologists to identify genetic mutations, biomarkers, and molecular signatures that drive cancer growth and progression, thereby guiding treatment selection and optimizing therapeutic outcomes. With a focus on personalized medicine approaches, molecular diagnostics companies and oncology centers are leveraging genomic data to tailor cancer treatment regimens to individual patients, improve response rates, and minimize treatment-related toxicities, thereby ushering in a new era of precision oncology and transformative cancer care.
Genomics in Cancer Care Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Genomics in Cancer Care market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Genomics in Cancer Care survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Genomics in Cancer Care industry.
Key market trends defining the global Genomics in Cancer Care demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Genomics in Cancer Care Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Genomics in Cancer Care industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Genomics in Cancer Care companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Genomics in Cancer Care industry
Leading Genomics in Cancer Care companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Genomics in Cancer Care companies.
Genomics in Cancer Care Market Study- Strategic Analysis Review
The Genomics in Cancer Care market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Genomics in Cancer Care industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Genomics in Cancer Care Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Genomics in Cancer Care Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Genomics in Cancer Care market segments. Similarly, Strong end-user demand is encouraging Canadian Genomics in Cancer Care companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Genomics in Cancer Care market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Genomics in Cancer Care Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Genomics in Cancer Care industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Genomics in Cancer Care market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Genomics in Cancer Care Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Genomics in Cancer Care in Asia Pacific. In particular, China, India, and South East Asian Genomics in Cancer Care markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Genomics in Cancer Care Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Genomics in Cancer Care Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Genomics in Cancer Care market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Genomics in Cancer Care.
Genomics in Cancer Care Market Company Profiles
The global Genomics in Cancer Care market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Bio-Rad Laboratories Inc, Cancer Genetics Inc, F. Hoffmann-La Roche AG, GE Healthcare, Illumina Inc, Intrexon Bioinformatics Germany GmbH, Luminex Corp, Merck KGaA, Myriad Genetics Inc, Pacific Biosciences of California Inc, Perkin Elmer, Qiagen NV, Quest Diagnostics, ThermoFisher Scientific Inc
Recent Genomics in Cancer Care Market Developments
The global Genomics in Cancer Care market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Genomics in Cancer Care Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others
Geographical Segmentation:
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The genomics in cancer care market is witnessing rapid growth, fueled by advancements in genomic technologies, increasing understanding of cancer biology, and expanding applications in precision oncology and targeted therapy. Genomic profiling of tumors enables oncologists to identify genetic mutations, biomarkers, and molecular signatures that drive cancer growth and progression, thereby guiding treatment selection and optimizing therapeutic outcomes. With a focus on personalized medicine approaches, molecular diagnostics companies and oncology centers are leveraging genomic data to tailor cancer treatment regimens to individual patients, improve response rates, and minimize treatment-related toxicities, thereby ushering in a new era of precision oncology and transformative cancer care.
Genomics in Cancer Care Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Genomics in Cancer Care market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Genomics in Cancer Care survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Genomics in Cancer Care industry.
Key market trends defining the global Genomics in Cancer Care demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Genomics in Cancer Care Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Genomics in Cancer Care industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Genomics in Cancer Care companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Genomics in Cancer Care industry
Leading Genomics in Cancer Care companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Genomics in Cancer Care companies.
Genomics in Cancer Care Market Study- Strategic Analysis Review
The Genomics in Cancer Care market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Genomics in Cancer Care industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Genomics in Cancer Care Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Genomics in Cancer Care Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Genomics in Cancer Care market segments. Similarly, Strong end-user demand is encouraging Canadian Genomics in Cancer Care companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Genomics in Cancer Care market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Genomics in Cancer Care Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Genomics in Cancer Care industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Genomics in Cancer Care market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Genomics in Cancer Care Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Genomics in Cancer Care in Asia Pacific. In particular, China, India, and South East Asian Genomics in Cancer Care markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Genomics in Cancer Care Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Genomics in Cancer Care Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Genomics in Cancer Care market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Genomics in Cancer Care.
Genomics in Cancer Care Market Company Profiles
The global Genomics in Cancer Care market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Bio-Rad Laboratories Inc, Cancer Genetics Inc, F. Hoffmann-La Roche AG, GE Healthcare, Illumina Inc, Intrexon Bioinformatics Germany GmbH, Luminex Corp, Merck KGaA, Myriad Genetics Inc, Pacific Biosciences of California Inc, Perkin Elmer, Qiagen NV, Quest Diagnostics, ThermoFisher Scientific Inc
Recent Genomics in Cancer Care Market Developments
The global Genomics in Cancer Care market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Genomics in Cancer Care Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Genomics in Cancer Care Market Overview and Key Findings, 2024
1.2 Genomics in Cancer Care Market Size and Growth Outlook, 2021- 2030
1.3 Genomics in Cancer Care Market Growth Opportunities to 2030
1.4 Key Genomics in Cancer Care Market Trends and Challenges
1.4.1 Genomics in Cancer Care Market Drivers and Trends
1.4.2 Genomics in Cancer Care Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Genomics in Cancer Care Companies
2. GENOMICS IN CANCER CARE MARKET SIZE OUTLOOK TO 2030
2.1 Genomics in Cancer Care Market Size Outlook, USD Million, 2021- 2030
2.2 Genomics in Cancer Care Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENOMICS IN CANCER CARE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENOMICS IN CANCER CARE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Genomics in Cancer Care Market, 2025
5.2 Asia Pacific Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Genomics in Cancer Care Market, 2025
5.5 Europe Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.6 Europe Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Genomics in Cancer Care Market, 2025
5.8 North America Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.9 North America Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Genomics in Cancer Care Market, 2025
5.11 South America Pacific Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.12 South America Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Genomics in Cancer Care Market, 2025
5.14 Middle East Africa Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Genomics in Cancer Care Market Size Outlook and Revenue Growth Forecasts
6.2 US Genomics in Cancer Care Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Genomics in Cancer Care Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Genomics in Cancer Care Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Genomics in Cancer Care Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Genomics in Cancer Care Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Genomics in Cancer Care Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Genomics in Cancer Care Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Genomics in Cancer Care Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Genomics in Cancer Care Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Genomics in Cancer Care Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Genomics in Cancer Care Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Genomics in Cancer Care Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Genomics in Cancer Care Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Genomics in Cancer Care Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Genomics in Cancer Care Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Genomics in Cancer Care Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Genomics in Cancer Care Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Genomics in Cancer Care Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Genomics in Cancer Care Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Genomics in Cancer Care Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Genomics in Cancer Care Industry Drivers and Opportunities
7. GENOMICS IN CANCER CARE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENOMICS IN CANCER CARE COMPANY PROFILES
8.1 Profiles of Leading Genomics in Cancer Care Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Genomics in Cancer Care Market Overview and Key Findings, 2024
1.2 Genomics in Cancer Care Market Size and Growth Outlook, 2021- 2030
1.3 Genomics in Cancer Care Market Growth Opportunities to 2030
1.4 Key Genomics in Cancer Care Market Trends and Challenges
1.4.1 Genomics in Cancer Care Market Drivers and Trends
1.4.2 Genomics in Cancer Care Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Genomics in Cancer Care Companies
2. GENOMICS IN CANCER CARE MARKET SIZE OUTLOOK TO 2030
2.1 Genomics in Cancer Care Market Size Outlook, USD Million, 2021- 2030
2.2 Genomics in Cancer Care Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENOMICS IN CANCER CARE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENOMICS IN CANCER CARE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Genomics in Cancer Care Market, 2025
5.2 Asia Pacific Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Genomics in Cancer Care Market, 2025
5.5 Europe Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.6 Europe Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Genomics in Cancer Care Market, 2025
5.8 North America Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.9 North America Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Genomics in Cancer Care Market, 2025
5.11 South America Pacific Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.12 South America Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Genomics in Cancer Care Market, 2025
5.14 Middle East Africa Genomics in Cancer Care Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Genomics in Cancer Care Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Genomics in Cancer Care Market Size Outlook and Revenue Growth Forecasts
6.2 US Genomics in Cancer Care Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Genomics in Cancer Care Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Genomics in Cancer Care Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Genomics in Cancer Care Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Genomics in Cancer Care Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Genomics in Cancer Care Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Genomics in Cancer Care Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Genomics in Cancer Care Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Genomics in Cancer Care Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Genomics in Cancer Care Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Genomics in Cancer Care Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Genomics in Cancer Care Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Genomics in Cancer Care Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Genomics in Cancer Care Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Genomics in Cancer Care Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Genomics in Cancer Care Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Genomics in Cancer Care Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Genomics in Cancer Care Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Genomics in Cancer Care Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Genomics in Cancer Care Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Genomics in Cancer Care Industry Drivers and Opportunities
7. GENOMICS IN CANCER CARE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENOMICS IN CANCER CARE COMPANY PROFILES
8.1 Profiles of Leading Genomics in Cancer Care Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
